Belperio John MD Los Angeles, CA - 90095

Belperio John MD is categorized under Internal Medicine Practitioners in Los Angeles, CA and active since 2010.

Belperio John MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact John Belperio at the company’s single location by writing to 200 Ucla Medical Plaza, Los Angeles, California CA 90095 or by phoning (310) 825-8061. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Belperio John MD
Contact Person: John Belperio
Address: 200 Ucla Medical Plaza, Los Angeles, California 90095
Phone Number: (310) 825-8061
Website Address: lung.med.ucla.edu
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Belperio John MD was started in 2010 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact John Belperio for inquiries that concern Belperio John MD by calling the company number (310) 825-8061, as your correspondence is most welcome. Additionally, the physical location of the single location of Belperio John MD can be found at the coordinates 34.07019,-118.45102 as well as the street address 200 Ucla Medical Plaza in Los Angeles, California 90095.

For its online presence, you may visit Belperio John MD’s website at lung.med.ucla.edu and engage with its social media outlets through on Twitter and on Facebook.